IP vs SPRO
International Paper (IP) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the IP and SPRO stock pages for the full models.
Not investment advice.